Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €42.22 ($45.40) and traded as high as €45.89 ($49.34). Fresenius Medical Care shares last traded at €45.40 ($48.82), with a volume of 439,037 shares traded.
Fresenius Medical Care Trading Down 0.3 %
The firm has a market capitalization of $13.39 billion, a PE ratio of 20.32, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a debt-to-equity ratio of 82.24, a current ratio of 1.37 and a quick ratio of 0.80. The company has a fifty day moving average of €45.45 and a 200-day moving average of €42.22.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Five stocks we like better than Fresenius Medical Care
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Find Undervalued Stocks
- Qualcomm Stock Is Coiling for a Breakout
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
